Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000935836-25-000447·Beryl Capital Management LLC
Schedule 13G ownership disclosure
ENZO BIOCHEM INC
Common Stock · CUSIP: 294100102
Event date: 2025-06-24
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Beryl Capital Management LLC
Shares: 5,069,789.00 · Class: 9.7%
- Beryl Capital Management LP
Shares: 5,069,789.00 · Class: 9.7%
- Beryl Capital Partners II LP
Shares: 4,088,352.00 · Class: 7.8%
- David A. Witkin
Shares: 5,069,789.00 · Class: 9.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000447
- Form type
- SCHEDULE 13G
- Filer
- Beryl Capital Management LLC
- CIK
- CIK 1719307
- Filed
- Jul 01, 2025
- Reporting period
- Jun 24, 2025
- Description
- Schedule 13G beneficial ownership